0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Death in Anticonvulsant-Induced Megaloblastic Anemia

Jack Pinkhas, MD; Mina Ben-Bassat, MD; Andre de Vries, MD
JAMA. 1973;224(2):246. doi:10.1001/jama.1973.03220150054019.
Text Size: A A A
Published online

To the Editor.—  Patients with megaloblastic anemia due to anticonvulsant treatment have been reported to die suddenly following institution of treatment, whether folic acid and vitamin B12 or blood transfusion.1 Their deaths have been ascribed to arrhythmia from hypokalemia developing during rapid red cell maturation and overloading of the circulation. We wish to report a patient with extreme anticonvulsant-induced megaloblastic anemia who died a short time following institution of treatment.

Report of a Case.—  In 1960 a 28-year-old epileptic man was diagnosed to have hemoglobin H thalassemia with a steady hemoglobin level of 7 to 8 gm/100 ml2 and has been treated since then with anti-convulsants including diphenylhydantoin sodium, phenobarbital sodium and primidone. He was admitted in November 1971 with agitation, confusion, and extreme pallor. He had gingival hypertrophy, engorged jugular veins, hepatosplenomegaly, pitting edema at the ankles, a 2/6 systolic murmur over the precordium, a regular

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();